Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAMUSCULAR, INTRAVENOUSGeneric

CEFTRIAXONE

CEFTRIAXONE SODIUM

Standard Dose
EQ 500MG BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview CEFTRIAXONE is listed in Drugs@FDA under application 210197 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient CEFTRIAXONE SODIUM Form and strength INJECTABLE;INTRAMUSCULAR, INTRAVENOUS - EQ 500MG BASE/VIAL Sponsor DEVA HOLDING AS Submission history Latest submission status date: 2024-01-12 00:00:00.

Structured Monograph

Clinical summary

Approval overview CEFTRIAXONE is listed in Drugs@FDA under application 210197 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CEFTRIAXONE SODIUM Form and strength INJECTABLE;INTRAMUSCULAR, INTRAVENOUS - EQ 500MG BASE/VIAL Sponsor DEVA HOLDING AS Submission history Latest submission status date: 2024-01-12 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.